| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Carisma Therapeutics Inc. | President and CEO, Director | Stock Option (Right to Buy) | 125K | Jun 17, 2024 | Direct | ||
| ARTELO BIOSCIENCES, INC. | Director | Stock Option (right to buy) | 1.08K | Feb 28, 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| CARM | Carisma Therapeutics Inc. | Jun 17, 2024 | 1 | $0 | 4 | Jun 18, 2024 | President and CEO, Director |
| ARTL | ARTELO BIOSCIENCES, INC. | Feb 28, 2024 | 12 | $0 | 4 | Mar 1, 2024 | Director |
| CARM | Carisma Therapeutics Inc. | Jan 31, 2024 | 1 | $0 | 4 | Feb 2, 2024 | President and CEO, Director |
| ARTL | ARTELO BIOSCIENCES, INC. | Aug 4, 2023 | 1 | $0 | 4 | Aug 8, 2023 | Director |
| ARTL | ARTELO BIOSCIENCES, INC. | Jun 30, 2023 | 1 | $0 | 4 | Jul 3, 2023 | Director |
| CARM | Carisma Therapeutics Inc. | Jun 6, 2023 | 1 | $0 | 4 | Jun 8, 2023 | President and CEO, Director |
| CARM | Carisma Therapeutics Inc. | Mar 7, 2023 | 2 | $0 | 4 | Mar 9, 2023 | President and CEO, Director |
| CARM | Carisma Therapeutics Inc. | Mar 7, 2023 | 0 | $0 | 3 | Mar 9, 2023 | President and CEO, Director |
| ARTL | ARTELO BIOSCIENCES, INC. | Jun 24, 2022 | 1 | $0 | 4 | Jun 27, 2022 | Director |
| ARTL | ARTELO BIOSCIENCES, INC. | Jul 16, 2021 | 1 | $0 | 4 | Jul 26, 2021 | Director |